Aeglea BioTherapeutics Announces Positive 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 2019 SSIEM Symposium

Press/Media

Period	3 Sep 2019

Media coverage

Title	Aeglea BioTherapeutics Announces Positive 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 2019 SSIEM Symposium
Media name/outlet	Markets Business Insider
Country/Territory	United States
Date	3/09/19
URL	www.quotenet.com/news/stocks/aeglea-biotherapeutics-announces-positive-20-dose-data-for-pegzilarginase-in-patients-with-arginase-1-deficiency-at-the-2019-ssiem-symposium-1028492804
Persons	George Diaz